Clinical Trials Directory

Explore 66,650 clinical trials worldwide

Showing 43801-43850 of 66,650 trials

Active filters:Status: Recruiting

Clinical Trials (66,650)

NCT05412914
Remimazolam and Propofol on the Left Ventricular Strain During Anesthesia Induction for Non-cardiac Surgery
PHASE4Recruiting
40 participants
Started: Jan 26, 2023 · Completed: Jan 1, 2024
1 condition1 sponsor1 location
NCT05720780
Rehabilitation Training With Music-support & Exercise Tolerance in COPD and CRF Patients.
NARecruiting
156 participants
Started: Jan 26, 2023 · Completed: Dec 31, 2025
1 condition1 sponsor6 locations
NCT05455697
Tafasitamab, Retifanlimab, and Rituximab in Combination With Standard Therapy for the Treatment of Diffuse Large B-cell Lymphoma
PHASE1/PHASE2Recruiting
35 participants
Started: Jan 26, 2023 · Completed: Jul 6, 2027
3 conditions1 sponsor1 location
NCT05499013
Study to Assess SLN124 in Patients With Polycythemia Vera
PHASE1/PHASE2Recruiting
65 participants
Started: Jan 26, 2023 · Completed: Jun 30, 2025
1 condition1 sponsor23 locations
NCT05209243
START-MET HS Prostate Cancer. : SbrT & Androgen Receptor Therapy METastatic HSPC
NARecruiting
266 participants
Started: Jan 26, 2023 · Completed: Jan 31, 2027
2 conditions1 sponsor2 locations
NCT05470491
Trial of Allogeneic Reduced-Intensity, HLA-Haploidentical Allogeneic Hematopoietic Cell Bone Marrow Transplantation Followed by Graft-versus-Host-Disease (GVHD) Prophylaxis With Cyclophosphamide, Bortezomib and Maraviroc for Hematologic Malignancies ...
PHASE1/PHASE2Recruiting
265 participants
Started: Jan 26, 2023 · Completed: Jul 30, 2027
2 conditions1 sponsor1 location
NCT05701553
Anti-PD-1/PD-L1 Antibodies Plus S-adenosyl-methionine Treatment in Patients With Advanced-Stage Hepatocellular Carcinoma
N/ARecruiting
20 participants
Started: Jan 26, 2023 · Completed: Dec 31, 2025
1 condition1 sponsor1 location
NCT05613049
Confounding Factors of Chronic Endometritis in Women With Reproductive Failure
N/ARecruiting
720 participants
Started: Jan 26, 2023 · Completed: Jan 31, 2028
1 condition1 sponsor1 location
NCT05835518
An Observational, Prospective Study to Assess the Efficacy and Safety of Adalloce in Patients With RA and AS
N/ARecruiting
1,000 participants
Started: Jan 26, 2023 · Completed: Aug 31, 2026
2 conditions1 sponsor1 location
NCT05743569
3D Specimen Maps for RT Planning
N/ARecruiting
13 participants
Started: Jan 26, 2023 · Completed: Dec 26, 2025
3 conditions1 sponsor1 location
NCT05685433
A Real World Study of eCoin for Urgency Urinary Incontinence: Post Approval Evaluation (RECIPE)
NARecruiting
200 participants
Started: Jan 26, 2023 · Completed: Dec 31, 2031
4 conditions1 sponsor22 locations
NCT05748730
Clinical Trial for Integrated Care to Help At Risk Teen (iCHART) Intervention
NARecruiting
900 participants
Started: Jan 26, 2023 · Completed: Apr 30, 2027
2 conditions6 sponsors13 locations
NCT05759923
First-in-human Phase I Study to Evaluate Safety, Tolerability and Antineoplastic Activity of OATD-02 in Patients with Selected Advanced And/or Metastatic Solid Tumours
PHASE1Recruiting
40 participants
Started: Jan 26, 2023 · Completed: Dec 31, 2025
8 conditions1 sponsor3 locations
NCT05528341
NKG2D-CAR-NK92 Cells Immunotherapy for Solid Tumors
PHASE1Recruiting
20 participants
Started: Jan 26, 2023 · Completed: Apr 30, 2026
1 condition1 sponsor1 location
NCT05500833
Multidimensional Characterization of Dyspnea in Children
N/ARecruiting
400 participants
Started: Jan 26, 2023 · Completed: Feb 25, 2026
1 condition1 sponsor1 location
NCT05551936
A Study of Tazemetostat With Rituximab and Abbreviated Bendamustine in the Frontline Treatment of High Tumor Burden Follicular Lymphoma
PHASE1/PHASE2Recruiting
42 participants
Started: Jan 26, 2023 · Completed: May 31, 2027
1 condition3 sponsors5 locations
NCT05498116
Effect of Montelukast on Kidney and Vascular Function in Type 1 Diabetes
PHASE4Recruiting
50 participants
Started: Jan 26, 2023 · Completed: Oct 31, 2025
1 condition1 sponsor1 location
NCT05522803
Can Transcranial Magnetic Stimulation Decrease Food Reinforcement
NARecruiting
12 participants
Started: Jan 26, 2023 · Completed: Jun 30, 2024
1 condition1 sponsor1 location
NCT05631756
Correlation Between PaO2/FiO2 and Lung Ultrasound Score in the Intensive Care Unit
NARecruiting
86 participants
Started: Jan 26, 2023 · Completed: Dec 30, 2024
1 condition1 sponsor2 locations
NCT05513326
Effectiveness of a 6-week Specific Rehabilitation Program on Walking Capacity in Patients with Lumbar Spinal Stenosis
NARecruiting
66 participants
Started: Jan 26, 2023 · Completed: Dec 31, 2025
1 condition1 sponsor1 location
NCT05496322
Continuous Vs Intermittent Non Invasive Blood Pressure Monitoring in Preventing Post Operative Organ Failure
NARecruiting
1,265 participants
Started: Jan 26, 2023 · Completed: Dec 31, 2025
3 conditions2 sponsors1 location
NCT05425030
A Community Health Worker-Led LSSS Intervention in Bangladesh
NARecruiting
1,000 participants
Started: Jan 26, 2023 · Completed: Dec 30, 2024
2 conditions3 sponsors1 location
NCT05769348
Investigation and Modulation of the Central Mu-Opioid Mechanism in Migraine (in Vivo)
NARecruiting
80 participants
Started: Jan 26, 2023 · Completed: Dec 30, 2025
1 condition2 sponsors1 location
NCT05571592
Cannabidiol as a Treatment for Social Anxiety Disorder (R61)
PHASE2Recruiting
60 participants
Started: Jan 26, 2023 · Completed: Aug 1, 2025
1 condition3 sponsors1 location
NCT05268107
Ethnic Differences in Mechanisms of Action of Dupilumab
PHASE4Recruiting
30 participants
Started: Jan 25, 2023 · Completed: Jun 30, 2026
1 condition2 sponsors1 location
NCT05527210
Prebiotic Treatment in People With Schizophrenia
NARecruiting
60 participants
Started: Jan 25, 2023 · Completed: Jan 31, 2026
2 conditions2 sponsors1 location
NCT05707780
Clinical Evaluation of Resin Matrix Ceramic Posterior Crowns
NARecruiting
90 participants
Started: Jan 25, 2023 · Completed: Oct 30, 2026
1 condition2 sponsors1 location
NCT06627881
Effect of Three Training Programs on the Cardiovascular Condition of Individuals with Spinal Cord Injury
NARecruiting
63 participants
Started: Jan 25, 2023 · Completed: Jan 30, 2026
3 conditions1 sponsor1 location
NCT05426200
Pre-transplant Health Coaching to Improve Patient-Reported Outcomes in Lung Transplant Candidates
NARecruiting
230 participants
Started: Jan 25, 2023 · Completed: Jan 31, 2027
1 condition1 sponsor3 locations
NCT05751408
Technical Evaluation of Commercial IMUs Within Clinical Gait Analysis
N/ARecruiting
40 participants
Started: Jan 25, 2023 · Completed: Jun 30, 2025
1 condition1 sponsor1 location
NCT05500092
An Open Label, Randomized Study of Neoadjuvant Nivolumab and Chemotherapy, With or Without Sub-ablative Stereotactic Body Radiation Therapy, for Resectable Stage IIA to IIIB Non-small Cell Lung Cancer
PHASE2Recruiting
52 participants
Started: Jan 25, 2023 · Completed: Jul 31, 2025
1 condition2 sponsors1 location
NCT05345483
REscue Stenting With CREDO® Heal for Recanalisation After Unsuccessful Thrombectomy (RECHRUT)
N/ARecruiting
153 participants
Started: Jan 25, 2023 · Completed: Jan 31, 2027
1 condition1 sponsor17 locations
NCT04679376
Statins for the Treatment of NASH
PHASE2Recruiting
70 participants
Started: Jan 25, 2023 · Completed: Dec 31, 2026
1 condition1 sponsor2 locations
NCT05640089
FMRI-neurofeedback in Depression
NARecruiting
120 participants
Started: Jan 25, 2023 · Completed: Apr 30, 2027
1 condition1 sponsor3 locations
NCT05486234
CARS: Cannabis and Alcohol Reduction Study
NARecruiting
52 participants
Started: Jan 25, 2023 · Completed: Mar 31, 2026
4 conditions2 sponsors1 location
NCT05670119
The Effect of Catheter-Associated Infection Control Training
NARecruiting
70 participants
Started: Jan 25, 2023 · Completed: Dec 30, 2023
1 condition1 sponsor1 location
NCT05714072
A Study of Ruxolitinib in Combination With Abemaciclib for the Treatment of Myelofibrosis
PHASE1Recruiting
18 participants
Started: Jan 25, 2023 · Completed: Jan 31, 2026
1 condition3 sponsors7 locations
NCT05714449
OCT Eccentric Fixation and Amblyopia in Children
NARecruiting
30 participants
Started: Jan 25, 2023 · Completed: Jan 24, 2026
1 condition1 sponsor1 location
NCT05703607
A Study to Learn About a Modified RNA Vaccine Against Shingles in Healthy Adults
PHASE2Recruiting
900 participants
Started: Jan 25, 2023 · Completed: Aug 20, 2030
3 conditions2 sponsors35 locations
NCT05582044
Exercise Lower-body Negative Pressure in Heart Failure With Preserved Ejection Fraction
NARecruiting
60 participants
Started: Jan 25, 2023 · Completed: Jan 31, 2026
1 condition1 sponsor1 location
NCT05624125
BEETroot Juice to Reverse Functional Impairment in PAD
NARecruiting
210 participants
Started: Jan 25, 2023 · Completed: Oct 1, 2028
1 condition4 sponsors4 locations
NCT05668260
Internal Biodegradable Stent Versus Non-Stent in Patients at High-Risk of Developing Fistula After Pancreatoduodenectomy
NARecruiting
122 participants
Started: Jan 25, 2023 · Completed: Sep 30, 2026
3 conditions2 sponsors1 location
NCT05157282
Spinal Cord Stimulation for Functional Recovery in Humans With Tetraplegia
NARecruiting
86 participants
Started: Jan 25, 2023 · Completed: Nov 4, 2025
1 condition1 sponsor2 locations
NCT05498597
AMT-151 in Patients With Selected Advanced Solid Tumours
PHASE1Recruiting
30 participants
Started: Jan 25, 2023 · Completed: Oct 30, 2024
19 conditions2 sponsors9 locations
NCT05674175
Co-administration of CART22-65s and huCART19 for B-ALL
PHASE1/PHASE2Recruiting
93 participants
Started: Jan 25, 2023 · Completed: Jan 15, 2029
2 conditions2 sponsors1 location
NCT05920330
Nasal Obstruction and Olfactory Losses
NARecruiting
330 participants
Started: Jan 25, 2023 · Completed: Dec 31, 2028
1 condition1 sponsor1 location
NCT06739473
Total-body Glucose Utilization in Obesity
PHASE4Recruiting
60 participants
Started: Jan 25, 2023 · Completed: Dec 31, 2024
1 condition1 sponsor1 location
NCT05713136
The National Australian HCV Point-of-Care Testing Program - HCV Antibody Testing Minimal Dataset
N/ARecruiting
40,000 participants
Started: Jan 25, 2023 · Completed: Jan 31, 2027
1 condition2 sponsors12 locations
NCT05529069
Phase II Study of Pirtobrutinib With Venetoclax In Relapsed-Refractory MCL (Mantle Cell Lymphoma) Patients
PHASE2Recruiting
30 participants
Started: Jan 25, 2023 · Completed: Apr 28, 2027
3 conditions2 sponsors1 location
NCT06458088
Advanced Glycation Products and Vascular Complications in Type 1 Diabetes
N/ARecruiting
196 participants
Started: Jan 25, 2023 · Completed: Dec 31, 2024
1 condition1 sponsor1 location